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FIG. 3. Survival of patients and acquisition of resistant Pseudomonas aeruginosa (PA). (a) Kaplan–Meier survival curves. Cases (blue line) vs. controls
(orange line); p-values are with borderline statistical signiﬁcance depending on method: log-rank 0.026, Breslow 0.071, Tarone-Ware 0.046. (b)
Acquisition of carbapenem-resistant ureidopenicillin-resistant PA (CRUR-PA) since index date (CRUS-PA, blue line; carbapenem-sensitive
ureidopenicillin-sensitive PA, grey line; carbapenem-sensitive ureidopenicillin-resistant PA, dark blue line). All three curves are signiﬁcantly different
one from the other (p-value <0.05).
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FIG. 4. Acquisition of carbapenem-resistant ureidopenicillin-resistant Pseudomonas aeruginosa (CRUR-PA) among carbapenem-resistant ure-
idopenicillin-susceptible PA (CRUS-PA) cases, according to the type of antibiotic exposure in a 6-month period. No antibiotic exposure prior to and
after the index date, black line; antibiotic exposure only prior to the index date, orange line; antibiotic exposure only after the index date, blue line;
antibiotic exposure before and after the index date, green line.
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